symbol,statement_type,period_end,line_item,value
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Ordinary Shares Number,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Share Issued,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net Debt,528626000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Debt,535602000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Tangible Book Value,311892000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Invested Capital,847594000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Working Capital,562118000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net Tangible Assets,311892000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Common Stock Equity,311992000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Capitalization,571606000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Equity Gross Minority Interest,312344000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Minority Interest,352000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Stockholders Equity,311992000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Retained Earnings,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Additional Paid In Capital,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Capital Stock,176686000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Common Stock,176686000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Liabilities Net Minority Interest,788206000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,260451000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Liabilities,-1000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,259614000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt,259614000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Provisions,838000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Liabilities,527755000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Current Liabilities,48222000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Deferred Taxes Liabilities,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Debt And Capital Lease Obligation,275988000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Debt,275988000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Provisions,15562000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Payables,187983000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Payable,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accounts Payable,187983000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Assets,1100550000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Assets,10677000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Assets,-1000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Prepaid Assets,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Assets,447000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Investments,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Investmentin Financial Assets,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Available For Sale Securities,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Goodwill And Other Intangible Assets,100000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Intangible Assets,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net PPE,10001000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accumulated Depreciation,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Gross PPE,10001000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Construction In Progress,180000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Properties,9821000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Machinery Furniture Equipment,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Buildings And Improvements,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Properties,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Assets,1089873000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Current Assets,8769000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Prepaid Assets,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Inventory,553861000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Finished Goods,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Receivables,101392000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accounts Receivable,418875000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,6976000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash And Cash Equivalents,6976000.0
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Equivalents,
MONOPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Financial,
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Ordinary Shares Number,17668564.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Share Issued,17668564.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net Debt,410777000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Debt,414404000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Tangible Book Value,280954000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Invested Capital,695493000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Working Capital,443470000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net Tangible Assets,280954000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Common Stock Equity,281089000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Capitalization,452338000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Equity Gross Minority Interest,281283000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Minority Interest,194000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Stockholders Equity,281089000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Retained Earnings,29647000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Additional Paid In Capital,74562000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Capital Stock,176880000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Common Stock,176880000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Liabilities Net Minority Interest,529844000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,171678000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Liabilities,
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,429000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,171249000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt,171249000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Provisions,
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Liabilities,358166000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Current Liabilities,
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Deferred Taxes Liabilities,6078000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Debt And Capital Lease Obligation,243155000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Debt,243155000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,147000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Provisions,
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Payables,104747000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Payable,7896000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accounts Payable,96851000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Assets,811127000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Assets,9491000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Assets,-2000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Prepaid Assets,250000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Assets,117000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Investments,
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Investmentin Financial Assets,0.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Available For Sale Securities,
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Goodwill And Other Intangible Assets,135000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Intangible Assets,135000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net PPE,8991000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accumulated Depreciation,-2576000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Gross PPE,11567000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Construction In Progress,
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Properties,5000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Machinery Furniture Equipment,6862000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Buildings And Improvements,4700000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Properties,0.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Assets,801636000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Current Assets,-1000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Prepaid Assets,59181000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Inventory,422926000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Finished Goods,422926000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Receivables,
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accounts Receivable,315903000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,3627000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash And Cash Equivalents,3627000.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Equivalents,0.0
MONOPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Financial,3627000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Ordinary Shares Number,17668564.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Share Issued,17668564.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net Debt,400801000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Debt,404978000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Tangible Book Value,133923000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Invested Capital,538901000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Working Capital,299196000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net Tangible Assets,133923000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Common Stock Equity,133923000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Capitalization,314027000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Equity Gross Minority Interest,133992000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Minority Interest,69000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Stockholders Equity,133923000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Retained Earnings,5349000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Additional Paid In Capital,4888000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Capital Stock,123686000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Common Stock,123686000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Liabilities Net Minority Interest,492033000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,180014000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Liabilities,-90000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,180104000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt,180104000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Provisions,
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Liabilities,312019000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Current Liabilities,2000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Deferred Taxes Liabilities,7322000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Debt And Capital Lease Obligation,224874000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Debt,224874000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,263000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Provisions,
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Payables,72127000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Payable,4369000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accounts Payable,67758000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Assets,626025000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Assets,14810000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Assets,-160000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Prepaid Assets,0.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Assets,549000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Investments,5734000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Investmentin Financial Assets,5734000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Available For Sale Securities,5734000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Goodwill And Other Intangible Assets,0.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Intangible Assets,
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net PPE,8687000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accumulated Depreciation,-1443000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Gross PPE,10130000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Construction In Progress,
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Properties,5000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Machinery Furniture Equipment,5425000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Buildings And Improvements,4700000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Properties,0.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Assets,611215000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Current Assets,150000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Prepaid Assets,61320000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Inventory,326861000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Finished Goods,326861000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Receivables,
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accounts Receivable,218707000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,4177000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash And Cash Equivalents,4177000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Equivalents,1424000.0
MONOPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Financial,2753000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Ordinary Shares Number,17668564.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Share Issued,17668564.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net Debt,61945000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Debt,64392000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Tangible Book Value,42757000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Invested Capital,107149000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Working Capital,54927000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net Tangible Assets,42757000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Common Stock Equity,42757000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Capitalization,57894000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Equity Gross Minority Interest,42757000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Minority Interest,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Stockholders Equity,42757000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Retained Earnings,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Additional Paid In Capital,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Capital Stock,42757000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Common Stock,42757000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Liabilities Net Minority Interest,101074000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,15138000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Liabilities,1000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,15137000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt,15137000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Provisions,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Liabilities,85936000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Current Liabilities,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Deferred Taxes Liabilities,1960000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Debt And Capital Lease Obligation,49255000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Debt,49255000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,679000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Provisions,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Payables,33758000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Payable,298000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accounts Payable,33460000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Assets,143831000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Assets,2968000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Assets,1000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Prepaid Assets,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Assets,0.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Investments,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Investmentin Financial Assets,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Available For Sale Securities,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Goodwill And Other Intangible Assets,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Intangible Assets,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net PPE,2967000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accumulated Depreciation,-3460000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Gross PPE,6427000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Construction In Progress,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Properties,14000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Machinery Furniture Equipment,6413000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Buildings And Improvements,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Properties,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Assets,140863000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Current Assets,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Prepaid Assets,36069000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Inventory,47137000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Finished Goods,47137000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Receivables,
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accounts Receivable,55210000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,2447000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash And Cash Equivalents,2447000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Equivalents,1883000.0
MONOPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Financial,564000.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Ordinary Shares Number,17668564.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Share Issued,17668564.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net Debt,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Debt,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Tangible Book Value,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Invested Capital,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Working Capital,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net Tangible Assets,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Common Stock Equity,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Capitalization,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Equity Gross Minority Interest,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Minority Interest,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Stockholders Equity,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Retained Earnings,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Additional Paid In Capital,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Capital Stock,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Common Stock,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Liabilities Net Minority Interest,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Liabilities,-1000.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Provisions,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Liabilities,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Current Liabilities,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Deferred Taxes Liabilities,719000.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Debt And Capital Lease Obligation,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Debt,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,459000.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Provisions,8000.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Payables,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Payable,753000.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accounts Payable,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Assets,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Assets,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Assets,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Prepaid Assets,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Assets,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Investments,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Investmentin Financial Assets,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Available For Sale Securities,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Goodwill And Other Intangible Assets,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Intangible Assets,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net PPE,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accumulated Depreciation,-2378000.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Gross PPE,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Construction In Progress,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Properties,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Machinery Furniture Equipment,6273000.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Buildings And Improvements,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Properties,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Assets,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Current Assets,-1000.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Prepaid Assets,11735000.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Inventory,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Finished Goods,41405000.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Receivables,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accounts Receivable,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash And Cash Equivalents,
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Equivalents,1700000.0
MONOPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Financial,32000.0
